Fine structural recognition specificities of IgE antibodies distinguishing amoxicilloyl and amoxicillanyl determinants in allergic subjects.
IgE antibodies in the sera of subjects allergic to beta-lactam antibiotics detect a spectrum of specificities ranging from side-chain groups to an entire penicillin or cephalosporin molecule. In addition to such structural heterogeneity of allergenic determinants, IgE antibodies in the sera of different allergic subjects show heterogeneous recognition responses. Detailed immunochemical studies were carried out on the sera of penicillin-allergic subjects that showed selective and unexpected reactions with the frequently prescribed penicillin, amoxicillin. Antibodies from one subject reacted only with the amoxicilloyl determinant while IgE from another subject showed multiple reactivity with penicilloyl and penicillanyl determinants of different penicillins but not with the amoxicilloyl determinant. Quantitative hapten inhibition studies revealed that the combining sites of the former antibodies were complementary to amoxicillin in a form that permits binding to the hydroxyaminobenzyl side-chain and the thiazolidine ring carboxyl. These conditions are satisfied with the drug in the '-oyl' but not in the '-anyl' form which involves linkage through the 2-carboxyl of the thiazolidine ring. With the second serum, adsorption studies showed that the wide-ranging reactivity of IgE was due to a single population of antibodies that detected a common specificity on the different penicillins. Combining site studies revealed clear recognition of the benzyl portion of the side-chain of benzylpenicilloyl, benzylpenicillanyl, ampicilloyl, ampicillanyl and amoxicillanyl determinants when free antibody access to the side-chain was possible but little or no recognition of the ring hydroxyl of amoxicillin. Such uninhibited access may not occur, however, when amoxicillin is conjugated in the '-oyl' form since opening the beta-lactam ring allows increased flexibility and rotation of the molecule and the possibility of close association of the hydroxyaminobenzyl side-chain of amoxicillin with the linked peptide carrier. In such close steric association, H-bonding involving the ring hydroxyl and amino acids of the carrier may prevent antibody access to the side-chain region of the amoxicilloyl determinant.
Zhao
Z
Z
Molecular Immunology Laboratory, Kolling Institute of Medical Research, Royal North Shore Hospital of Sydney, St Leonards, NSW 2065, Australia.
Baldo
B A
BA
Baumgart
K W
KW
Mallon
D F
DF
D000327:Adsorption; D000328:Adult; D000368:Aged; D000658:Amoxicillin / Q000737:chemistry* / Q000494:pharmacology*; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000915:Antibody Affinity; D001249:Asthma / Q000276:immunology / Q000378:metabolism; D001665:Binding Sites; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D006860:Hydrogen Bonding; D006967:Hypersensitivity / Q000276:immunology* / Q000378:metabolism; D007073:Immunoglobulin E / Q000097:blood / Q000737:chemistry* / Q000276:immunology*; D020128:Inhibitory Concentration 50; D008297:Male; D008956:Models, Chemical; D008958:Models, Molecular; D010003:Osteoarthritis / Q000276:immunology / Q000378:metabolism; D011485:Protein Binding; D011863:Radioimmunoassay; D012220:Rhinitis / Q000276:immunology* / Q000378:metabolism
D000900:Anti-Bacterial Agents; D007073:Immunoglobulin E; D000658:Amoxicillin